QuidelOrtho Corporation (QDEL) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
QuidelOrtho Corporation (QDEL) Bundle
Simplify QuidelOrtho Corporation (QDEL) valuation with this customizable DCF Calculator! Featuring real QuidelOrtho Corporation (QDEL) financials and adjustable forecast inputs, you can test scenarios and uncover QuidelOrtho Corporation (QDEL) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 534.9 | 1,661.7 | 1,698.6 | 3,266.0 | 2,997.8 | 3,075.1 | 3,154.3 | 3,235.6 | 3,319.0 | 3,404.6 |
| Revenue Growth, % | 0 | 210.66 | 2.22 | 92.28 | -8.21 | 2.58 | 2.58 | 2.58 | 2.58 | 2.58 |
| EBITDA | 143.8 | 1,090.7 | 955.4 | 1,093.5 | 545.6 | 1,232.8 | 1,264.5 | 1,297.1 | 1,330.6 | 1,364.9 |
| EBITDA, % | 26.88 | 65.64 | 56.25 | 33.48 | 18.2 | 40.09 | 40.09 | 40.09 | 40.09 | 40.09 |
| Depreciation | 51.8 | 49.1 | 54.4 | 283.6 | 457.2 | 244.6 | 250.9 | 257.4 | 264.0 | 270.8 |
| Depreciation, % | 9.68 | 2.95 | 3.2 | 8.68 | 15.25 | 7.95 | 7.95 | 7.95 | 7.95 | 7.95 |
| EBIT | 92.0 | 1,041.6 | 901.1 | 809.9 | 88.4 | 988.2 | 1,013.6 | 1,039.8 | 1,066.6 | 1,094.0 |
| EBIT, % | 17.19 | 62.68 | 53.05 | 24.8 | 2.95 | 32.13 | 32.13 | 32.13 | 32.13 | 32.13 |
| Total Cash | 52.8 | 489.9 | 802.8 | 345.0 | 167.3 | 632.0 | 648.3 | 665.0 | 682.1 | 699.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 94.5 | 529.2 | 378.0 | 586.4 | 488.4 | 652.0 | 668.8 | 686.0 | 703.7 | 721.9 |
| Account Receivables, % | 17.67 | 31.85 | 22.25 | 17.95 | 16.29 | 21.2 | 21.2 | 21.2 | 21.2 | 21.2 |
| Inventories | 58.1 | 113.8 | 198.8 | 524.1 | 577.8 | 398.1 | 408.4 | 418.9 | 429.7 | 440.8 |
| Inventories, % | 10.86 | 6.85 | 11.7 | 16.05 | 19.27 | 12.95 | 12.95 | 12.95 | 12.95 | 12.95 |
| Accounts Payable | 26.7 | 86.3 | 101.5 | 283.3 | 294.8 | 213.2 | 218.7 | 224.4 | 230.1 | 236.1 |
| Accounts Payable, % | 4.99 | 5.19 | 5.98 | 8.67 | 9.83 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 |
| Capital Expenditure | -27.2 | -64.9 | -292.7 | -140.9 | -209.3 | -230.8 | -236.7 | -242.9 | -249.1 | -255.5 |
| Capital Expenditure, % | -5.09 | -3.91 | -17.23 | -4.31 | -6.98 | -7.51 | -7.51 | -7.51 | -7.51 | -7.51 |
| Tax Rate, % | 65.29 | 65.29 | 65.29 | 65.29 | 65.29 | 65.29 | 65.29 | 65.29 | 65.29 | 65.29 |
| EBITAT | 86.9 | 811.3 | 704.7 | 603.9 | 30.7 | 711.2 | 729.5 | 748.3 | 767.6 | 787.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -14.4 | 364.7 | 547.8 | 394.6 | 334.4 | 659.5 | 722.1 | 740.7 | 759.8 | 779.4 |
| WACC, % | 5.9 | 5.36 | 5.37 | 5.26 | 3.98 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 3,143.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 795 | |||||||||
| Terminal Value | 25,046 | |||||||||
| Present Terminal Value | 19,462 | |||||||||
| Enterprise Value | 22,606 | |||||||||
| Net Debt | 2,495 | |||||||||
| Equity Value | 20,110 | |||||||||
| Diluted Shares Outstanding, MM | 67 | |||||||||
| Equity Value Per Share | 301.06 |
What You Will Get
- Real QDEL Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Automatic Calculations: Dynamic calculations for intrinsic value and NPV.
- Scenario Analysis: Evaluate various scenarios to assess QuidelOrtho’s future performance.
- Clear and Intuitive Design: Designed for professionals while remaining user-friendly for newcomers.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical performance and future forecasts for QuidelOrtho Corporation (QDEL).
- Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic adjustments to DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Intuitive charts and summaries to effectively present your valuation findings.
- Designed for All Users: A straightforward and accessible layout tailored for investors, CFOs, and consultants alike.
How It Works
- Download the Template: Gain immediate access to the Excel-based QDEL DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates QuidelOrtho’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial decisions.
Why Choose This Calculator for QuidelOrtho Corporation (QDEL)?
- Accurate Data: Up-to-date QuidelOrtho financials provide dependable valuation outcomes.
- Customizable: Tailor critical variables such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Healthcare Professionals: Understand diagnostic testing methodologies and their applications in real-world scenarios.
- Researchers: Utilize advanced models for studies and incorporate them into your health-related research.
- Investors: Evaluate your investment strategies and analyze the market performance of QuidelOrtho Corporation (QDEL).
- Analysts: Enhance your analysis process with a customizable financial model tailored for the diagnostics sector.
- Medical Device Entrepreneurs: Learn from the operational strategies of established companies like QuidelOrtho Corporation.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for QuidelOrtho Corporation (QDEL).
- Real-World Data: QuidelOrtho’s historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore different scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to QuidelOrtho Corporation (QDEL).
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results regarding QuidelOrtho Corporation (QDEL).